公司資料
ACADIA Pharmaceuticals Inc. 股價、新聞與催化劑
- 股票代碼:
- ACAD
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
19.89 USD (-1.29%)
收盤價
最後更新: 2026年10月1日
3.58B USD
市值
股價為何變動
截至 2026年10月1日，ACAD 下跌 1.29%，收於 $19.89。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Acadia Pharmaceuticals is a biopharmaceutical company focused on neuroscience and rare disease, with commercial products in areas such as psychosis and movement disorders. Its business combines marketed therapies with a pipeline aimed at CNS and specialty indications.
所在地與產業分類
Acadia is headquartered in the United States and listed on NASDAQ. It sits in specialty neuroscience biopharma.
商業模式特徵
The company depends on product sales, launch execution, and pipeline expansion across CNS and rare disease. Investors watch revenue growth, label breadth, and development milestones.
生技產業定位
Acadia occupies a strong specialty-neuroscience niche within biotech. It has more commercial footing than a typical development-stage company, but still reacts to pipeline and launch developments.
未來催化劑
- Acadia’s catalysts are DAYBUE execution, near-term CNS franchise updates, and any label / commercial step that broadens the company’s growth base. The company’s value depends on turning its CNS assets into a more durable franchise.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。